Cargando…
Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer
Various studies have shown that the cell-cycle-related regulatory proteins UBE2C, PLK1, and BIRC5 promote cell proliferation and migration in different types of cancer. However, there is a lack of in-depth and systematic research on the mechanism of these three as therapeutic targets. In this study,...
Autores principales: | Liang, Keying, Wang, Qian, Qiu, Li, Gong, Xiaocheng, Chen, Zixi, Zhang, Haibo, Ding, Ke, Liu, Yunfei, Wei, Jinfen, Lin, Shudai, Fu, Shuying, Du, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650476/ https://www.ncbi.nlm.nih.gov/pubmed/37958642 http://dx.doi.org/10.3390/ijms242115658 |
Ejemplares similares
-
KAT2A/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer
por: Lin, Shudai, et al.
Publicado: (2022) -
PRR11 promotes cell proliferation by regulating PTTG1 through interacting with E2F1 transcription factor in pan-cancer
por: Zhang, Haibo, et al.
Publicado: (2022) -
Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data
por: Wei, Jinfen, et al.
Publicado: (2020) -
Cucurbitacin I Reverses Tumor-Associated Macrophage Polarization to Affect Cancer Cell Metastasis
por: Gong, Xiaocheng, et al.
Publicado: (2023) -
A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer
por: Ding, Ke, et al.
Publicado: (2022)